A systematic review on durability and structural valve deterioration in TAVR and surgical AVR
- PMID: 33302806
- DOI: 10.1080/00015385.2020.1858250
A systematic review on durability and structural valve deterioration in TAVR and surgical AVR
Abstract
Mechanical valves and bioprosthetic heart valves are widely used for aortic valve replacement (AVR). Mechanical valves are associated with risk of bleeding because of oral anticoagulation, while the durability and structural valve deterioration (SVD) represent the main limitation of the bioprosthetic heart valves. The implantation of bioprosthetic heart valves is increasing precipitously due aging population, and the widespread use of transcatheter aortic valve replacement (TAVR). TAVR has become the standard treatment for intermediate or high surgical risk patients and a reasonable alternative to surgery for low risk patients with symptomatic severe aortic stenosis. Moreover, TAVR is increasingly being used for younger and lower-risk patients with longer life expectancy; therefore it is important to ensure the valve durability for long-term transcatheter aortic valves. Although the results of mid-term durability of the transcatheter heart valves are encouraging, their long-term durability remains largely unknown. This review summarises the definitions, mechanisms, risk factors and assessment of SVD; overviews available data on surgical bioprosthetic and transcatheter heart valves durability.
Keywords: Bioprosthetic heart valves; durability; structural valve deterioration; transcatheter aortic valve implantation; transcatheter heart valves.
Similar articles
-
Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.Circ Cardiovasc Interv. 2019 Apr;12(4):e007597. doi: 10.1161/CIRCINTERVENTIONS.118.007597. Circ Cardiovasc Interv. 2019. PMID: 30998397
-
Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.J Am Coll Cardiol. 2019 Feb 12;73(5):546-553. doi: 10.1016/j.jacc.2018.10.083. J Am Coll Cardiol. 2019. PMID: 30732707 Clinical Trial.
-
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves.JACC Cardiovasc Interv. 2022 Sep 26;15(18):1777-1793. doi: 10.1016/j.jcin.2022.07.035. JACC Cardiovasc Interv. 2022. PMID: 36137681 Review.
-
Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.Heart. 2018 Aug;104(16):1323-1332. doi: 10.1136/heartjnl-2017-311582. Epub 2018 May 7. Heart. 2018. PMID: 29735584 Review.
-
Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration.Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):132-141. doi: 10.14797/mdcj-13-3-132. Methodist Debakey Cardiovasc J. 2017. PMID: 29743998 Free PMC article. Review.
Cited by
-
Predictors of Mid-Term AVNeo Insufficiency.Braz J Cardiovasc Surg. 2023 Oct 5;38(6):e20220370. doi: 10.21470/1678-9741-2022-0370. Braz J Cardiovasc Surg. 2023. PMID: 37797236 Free PMC article.